DMK Pharmaceuticals (DMK) has released an update to notify the public and investors about the submission of matters to a vote of security holders.
DMK Pharmaceuticals Corporation held its reconvened annual stockholders’ meeting virtually on January 25, 2024, where a quorum was present with 4,720,351 shares represented. Five director candidates were elected to the board, amendments to the 2020 Equity Incentive Plan were approved, the executive officers’ compensation was approved on a non-binding advisory basis, and the selection of BDO USA, P.A. as the independent registered public accounting firm for the year ending December 31, 2023, was ratified.
For further insights into DMK corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.
